Immunopathologic changes in patients with cutaneous malignant melanoma following intratumoral inoculation of BCG: Correlation with cell-mediated immunity
- 15 September 1974
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 14 (3), 401-416
- https://doi.org/10.1002/ijc.2910140315
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Augmentation of the Adoptive Transfer of Specific Tumor Immunity by Nonspecifically Immunized Macrophages2JNCI Journal of the National Cancer Institute, 1973
- BCG immunotherapy of local subcutaneous growths and post‐surgical pulmonary metastases of a transplanted rat epithelioma of spontaneous originInternational Journal of Cancer, 1973
- Halo Nevi and MelanomaPublished by American Medical Association (AMA) ,1973
- Immunologic Effects of BCG in Patients With Malignant Melanoma: Specific Evidence for Stimulation of the “Secondary” Immune ResponseJNCI Journal of the National Cancer Institute, 1973
- Inhibition of hepatoma‐immune lymph‐node cell cytotoxicity by tumour‐bearer serum, and solubilized hepatoma antigenInternational Journal of Cancer, 1973
- Immunological Effects of BCG in Malignant Melanoma: Two Modes of Administration ComparedAnnals of Internal Medicine, 1972
- Human Tumor ImmunologyMedical Clinics of North America, 1971
- TUBERCULIN‐INDUCED MIGRATION INHIBITION OF HUMAN PERIPHERAL LEUCOCYTES IN AGAROSE MEDIUMAllergy, 1971
- IMMUNOLOGICAL SURVEILLANCEPublished by Elsevier ,1970
- “Lymphokines”: Non-Antibody Mediators of Cellular Immunity generated by Lymphocyte ActivationNature, 1969